Su1818 – Preclinical Efficacy and Safety of Nx-13: A Novel...

Gastroenterology 2019 / 05 Vol. 156; Iss. 6

Su1818 – Preclinical Efficacy and Safety of Nx-13: A Novel Nlrx1-Targeting Immunometabolic Therapeutic for Crohn’s Disease and Ulcerative Colitis

Leber, Andrew, Hontecillas, Raquel, Zoccoli-Rodriguez, Victoria, Chauhan, Jyoti, Bassaganya-Riera, Josep
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)38455-0
Date:
May, 2019
File:
PDF, 66 KB
english, 2019
Conversion to is in progress
Conversion to is failed